Radiopaque nano and polymeric materials for atherosclerosis imaging, embolization and other catheterization

Li Tian1, Linfeng Lu1, James Feng2

  • 1Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Insights

This review covers radiopaque materials for imaging and treating atherosclerosis, a major cause of cardiovascular disease (CVD). It highlights advancements in radiopaque agents and devices used in catheterization procedures for CVD diagnosis and treatment.

Area of Science:

  • Biomaterials Science
  • Medical Imaging
  • Cardiovascular Medicine

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of death, with atherosclerosis being a major contributor.
  • Effective imaging and interventional tools are crucial for managing CVDs.

Purpose of the Study:

  • To review radiopaque nano and polymeric materials for atherosclerosis imaging and catheterization procedures.
  • To discuss recent progress in radiopaque imaging agents and devices for CVD diagnosis and treatment.

Main Methods:

  • Review of the physics of radiopacity and X-ray/CT.
  • Discussion of clinically used contrast agents.
  • Analysis of recent developments in radiopaque materials for medical applications.

Main Results:

  • Exploration of radiopaque imaging agents for atherosclerosis.
  • Overview of radiopaque embolic agents, drug-eluting beads, and medical devices for catheterization.
  • Presentation of strategies for introducing radiopacity in polymers and their applications.

Conclusions:

  • Radiopaque materials play a vital role in advancing the diagnosis and treatment of cardiovascular diseases.
  • Ongoing research in radiopaque polymers and agents offers promising solutions for atherosclerosis management and catheterization procedures.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.5K
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.1K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
753
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
433
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
751